Dr Bridget Bax is a Reader in Rare Disease at St. George’s University of London and Deputy Head of Cell Biology, based in the Institute of Molecular and Clinical Sciences. Her research focuses on the understanding the molecular mechanisms that underlie rare diseases and on the development of cell-based therapies for their treatment. Dr Bax has a particular interest in the ultra-rare disease, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
Research Keywords & Expertise
Rare Diseases
Biomarkers discovery/d...
MNGIE
Enzyme replacement
Erythrocyte carrriers
Fingerprints
27%
MNGIE
18%
Enzyme replacement
9%
Rare Diseases
Short Biography
Dr Bridget Bax is a Reader in Rare Disease at St. George’s University of London and Deputy Head of Cell Biology, based in the Institute of Molecular and Clinical Sciences. Her research focuses on the understanding the molecular mechanisms that underlie rare diseases and on the development of cell-based therapies for their treatment. Dr Bax has a particular interest in the ultra-rare disease, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).